Patents Assigned to Unlearn.Al, Inc.
  • Patent number: 12051487
    Abstract: Systems and methods for determining treatment effects of a randomized control trial (RCT) in accordance with embodiments of the invention are illustrated. One embodiment includes a method for determining treatment effects. The method includes steps for receiving data from a RCT, generating result data using a set of one or more generative models, and determining treatment effects for the RCT using the generated result data.
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: July 30, 2024
    Assignee: Unlearn.Al, Inc.
    Inventors: Charles Kenneth Fisher, Aaron Michael Smith, Jonathan Ryan Walsh
  • Publication number: 20210057108
    Abstract: Systems and methods for determining treatment effects of a randomized control trial (RCT) in accordance with embodiments of the invention are illustrated. One embodiment includes a method for determining treatment effects. The method includes steps for receiving data from a RCT, generating result data using a set of one or more generative models, and determining treatment effects for the RCT using the generated result data.
    Type: Application
    Filed: August 19, 2020
    Publication date: February 25, 2021
    Applicant: Unlearn.Al, Inc.
    Inventors: Charles Kenneth Fisher, Aaron Michael Smith, Jonathan Ryan Walsh